首页|期刊导航|Cancer Biology & Medicine|A novel biguanide-derivative promotes NEDD4-mediated FGFR1 ubiquitination through BMI1 to overcome osimertinib resistance in NSCLC
Cancer Biology & Medicine2025,Vol.22Issue(11):P.1381-1404,24.DOI:10.20892/j.issn.2095-3941.2025.0209
A novel biguanide-derivative promotes NEDD4-mediated FGFR1 ubiquitination through BMI1 to overcome osimertinib resistance in NSCLC
摘要
关键词
NSCLC/biguanide/FGFR1 ubiquitination/BMI1/osimertinib resistance分类
医药卫生引用本文复制引用
Mei Peng,Weifan Wang,Di Xiao,Duo Li,Jun Deng,Hui Zou,Xing Feng,Yunhai Yang,Songqing Fan,Xiaoping Yang..A novel biguanide-derivative promotes NEDD4-mediated FGFR1 ubiquitination through BMI1 to overcome osimertinib resistance in NSCLC[J].Cancer Biology & Medicine,2025,22(11):P.1381-1404,24.基金项目
supported by grants from the National Natural Science Foundation of China(Grant Nos.82172653 and 82472728) (Grant Nos.82172653 and 82472728)
the Key Project of Developmental Biology and Breeding from Hunan Province(Grant No.2022XKQ0205) (Grant No.2022XKQ0205)
the Research Team for Reproduction Health and Translational Medicine of Hunan Normal University(Grant No.2023JC101) (Grant No.2023JC101)
the Natural Science Foundation of Hunan Province(Grant No.2025JJ80150). (Grant No.2025JJ80150)